U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06974097) titled 'TUMOR ASSOCIATED NEUTROPHILS AS A BIOMARKER OF CHEMO-IMMUNOTHERAPY RESPONSE IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: a Model Based on NEOADJUVANT STRATEGY' on May 07.
Brief Summary: evaluate the predictive value of circulating neutrophil DNA methylation profiles, identified from the ALCINA 2 cohort, on pre-treatment blood samples (T0), for the histological response to neoadjuvant chemo-immunotherapy in patients with resectable non-small cell lung cancer (NSCLC)
Study Start Date: June 01
Study Type: OBSERVATIONAL
Condition:
Non-Small Cell Lung Cancer
Intervention:
OTHER: blood sampling
blood sampling
Recruitment Status:...